Immune Checkpoint Inhibitor–Associated Pericarditis-Reference-Cited by-同舟云学术

Immune Checkpoint Inhibitor–Associated Pericarditis

Published:2019-06 Issue:6 Volume:14 Page:1102-1108
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Altan Mehmet,Toki Maria I.,Gettinger Scott N.,Carvajal-Hausdorf Daniel E.,Zugazagoitia Jon,Sinard John H.,Herbst Roy S.,Rimm David L.

Funder

Bristol-Myers Squibb

Lilly

Genentech

Yale SPORE in Lung Cancer

Yale Cancer Center CCSG

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. Suspected autoimmune myocarditis and cardiac conduction abnormalities with nivolumab therapy for non–small cell lung cancer;Gibson;BMJ Case Rep,2016

2. Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma;Läubli;J Immunother Cancer,2015

3. Myocarditis associated with immune checkpoint inhibitors: an expert consensus on data gaps and a call to action;Neilan;Oncologist,2018

4. Clinical features, management, and outcomes of immune checkpoint inhibitor-related cardiotoxicity;Escudier;Circulation,2017

5. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis;Wang;JAMA Oncol,2018

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors;Basic Research in Cardiology;2024-07-17

2. Cardiotoxicity mechanisms of antitumor therapy with immune checkpoint inhibitors: new achievements;Rational Pharmacotherapy in Cardiology;2024-05-24

3. Isolated Pericardial Effusion Without Associated Myocarditis in a Small-Cell Lung Cancer Patient Undergoing Atezolizumab Therapy;Cureus;2024-05-13

4. Immune checkpoint inhibitor-associated cardiovascular toxicities: A review;Heliyon;2024-03

5. Immune checkpoint inhibitor-induced myopericarditis;BMJ Case Reports;2024-03